M
Marc A. Koopmanschap
Researcher at Erasmus University Rotterdam
Publications - 183
Citations - 13455
Marc A. Koopmanschap is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Health care & Cost effectiveness. The author has an hindex of 61, co-authored 181 publications receiving 12475 citations. Previous affiliations of Marc A. Koopmanschap include Erasmus University Medical Center & University of Amsterdam.
Papers
More filters
Journal ArticleDOI
The friction cost method for measuring indirect costs of disease.
TL;DR: These estimates are considerably lower than estimates based on the traditional human capital approach, but they better reflect the economic impact of illness.
Journal ArticleDOI
Handbook of Health Economics
TL;DR: The book focuses on the US literature and health care system with 24 chapters written by US authors and only 11 by European and Canadian authors, and the structure both reflects the contributions in the health economics literature and the large variation in US health care institutions.
Journal ArticleDOI
Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes
W. Ken Redekop,Marc A. Koopmanschap,Ronald P. Stolk,Guy E.H.M. Rutten,Bruce H. R. Wolffenbuttel,Louis W. Niessen +5 more
TL;DR: Obesity and the presence of complications are important determinants of HRQOL in patients with type 2 diabetes in the Netherlands and which patient characteristics are associated with quality of life and treatment satisfaction are examined.
Journal ArticleDOI
Economic valuation of informal care. An overview of methods and applications
TL;DR: A critical evaluation of the available methods to incorporate informal care in economic evaluations is presented, both in terms of morbidity and mortality and theoretically sound and easily applicable valuation methods.
Journal ArticleDOI
Demographic and epidemiological determinants of healthcare costs in Netherlands: cost of illness study
TL;DR: The main determinants of healthcare use in the Netherlands are old age and disabling conditions, particularly mental disability, and this cost will inevitably increase further in an ageing population.